inPROBE
Clinical Data
Open label, multicenter, single arm, Clinical Investigation of inPROBE
for the assessment of HER2 receptor expression in breast cancer completed in March 2023
Study results
relative to the existing diagnostic standard IHC/ISH
We Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.